MDACC Study No:2007-0637 ( NCT No: NCT00777192)
Title:Prospective Study of Symptoms Related to Oxaliplatin-based Regimens in the Treatment of Colorectal Cancer
Principal Investigator:Xin Shelley Wang
Treatment Agent:Questionnaire
Study Status:Closed
Study Description:The goal of this research study is to learn more about the pain and/or other
symptoms that patients may experience within five years from CRC diagnosis.
Researchers also want to learn how genetic differences may affect the symptoms
patients experience from cancer and cancer therapy.
Hide details for General InformationGeneral Information

Disease Group:Colorectal
Phase of Study:N/A
Treatment Agents:Questionnaire
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:no required hospital stay.
Supported By:Astra Zeneca
Return Visit:Patients will have a clinic visit at every cycle of chemotherapy that is
scheduled by treating physicians.
Home Care:No.

Hide details for Study Contact InformationStudy Contact Information

Physician Name:Xin Shelley Wang
Dept:Symptom Research
For Clinical Trial Enrollment:713-745-3470
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults